KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Accumulated Expenses (2018 - 2019)

Arbutus Biopharma's Accumulated Expenses history spans 4 years, with the latest figure at $137000.0 for Q4 2019.

  • For Q4 2019, Accumulated Expenses changed N/A year-over-year to $137000.0; the TTM value through Dec 2019 reached $137000.0, changed N/A, while the annual FY2019 figure was $137000.0, N/A changed from the prior year.
  • Accumulated Expenses for Q4 2019 was $137000.0 at Arbutus Biopharma, down from $203000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.9 million in Q2 2015 and bottomed at $28000.0 in Q1 2015.